Clinical Trial Update: Single and Multiple Dose Study in Japanese Subjects [Phase 1]

View source ↗

Summary

Phase 1 single and multiple dose study in Japanese subjects for gout-related lesinurad has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• Zurampic (lesinurad) (lesinurad)

Snippet

Sponsor: Ardea Biosciences, Inc. | Conditions: Gout | Phase 1 | Status: COMPLETED